Preventing or delaying the onset of end-stage kidney disease is vital. By implementing a results-driven, value-based approach, Dallas Nephrology Associates has demonstrated improved patient outcomes and value for payers.
Alexander Liang, MD
Advertisement
Articles by Alexander Liang, MD
Advertisement
Latest Updated Articles
Dallas Nephrology Associates’ Journey to Value-Based CarePublished: December 10th 2024 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
3
Real-World Data Key to Optimizing CAR T-Cell Therapy Delivery, Outcomes
4
Key Federal Legislation Impacting Managed Care Pharmacy: Geni Tunstall, JD
5
